LXRX Stock Analysis: Buy, Sell, or Hold?
LXRX - Lexicon Pharmaceuticals, Inc.
$2.17
-0.05 (-2.25%)
▼
5d:
-6.47%
30d:
+15.43%
90d:
+26.16%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026
21d
Smart Money Accumulation
None View Scanner →
Strength: 5.6/10
Get Alerted When LXRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LXRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LXRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LXRX is currently trading at $2.17, which is considered fair relative to its 30-day fair value range of $1.93 to $2.37.
Technical Outlook: Technically, LXRX is in a strong uptrend. The price is currently testing key support at $2.14. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.77 (+73.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LXRX is in a strong uptrend. The price is currently testing key support at $2.14. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.77 (+73.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.93 -
$2.37
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 73.7% below Wall St target ($3.77)
- CAUTION: Recommendation downgraded due to -6.5% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.93 -
$2.37
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.14
Resistance Level
$2.68
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.52
Wall Street Target
$3.77
(+73.7%)
Revenue Growth (YoY)
1572.1%
Earnings Growth (YoY)
-63.4%
Profit Margin
-37.5%
Share & Embed Analysis
Last updated: July 14, 2026 6:16 AM ET
Data refreshes hourly during market hours. Next update: 7:16 AM
Data refreshes hourly during market hours. Next update: 7:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LXRX showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Raymond Debbane
BUY
2000 shares
2026-02-25
Raymond Debbane
BUY
100000 shares
2026-02-23
Raymond Debbane
BUY
100000 shares
2026-02-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 60 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |